GGrantIndex
Sort

82,697 grants matching vaccine development

Emerging Infectious Diseases Research Centers Coordination Center (EIDRC CC)

$2,450,928
Gregory D Sempowski · Research Triangle Institute · U01 · FY2023 · AI

Genetic and Biochemical Approaches to Tyrosine Kinase and Lymphocyte Signaling

$2,450,539
Pamela Schwartzberg · National Human Genome Research Institute · ZIA · FY2017 · HG

SPORE in Cervical Cancer

$2,450,204
Johns Hopkins University · P50 · FY2004 · CA

Enhanced Surveillance for New Vaccine Preventable Diseases

$2,450,000
Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2019 · IP

Variation in M. tuberculosis in response to host selection

$2,449,750
Sarah M Fortune · Harvard School Of Public Health · DP2 · FY2007 · OD

Fred Hutchinson Cancer Research Center Lung SPORE

$2,447,085
A. McGarry Houghton · Fred Hutchinson Cancer Center · P50 · FY2023 · CA

Fred Hutchinson Cancer Research Center Lung SPORE

$2,447,059
A. McGarry Houghton · Fred Hutchinson Cancer Center · P50 · FY2022 · CA

Preventive Vaccines for HIV

$2,446,406
Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Northwestern University Clinical Trial Unit

$2,446,296
Robert L. Murphy · Northwestern University At Chicago · U01 · FY2011 · AI

Durable Alteration of the Human Immune system after Infection or Immunotherapy

$2,446,152
Raymond T Chung · Massachusetts General Hospital · U19 · FY2024 · AI

Malaria Vaccine: AMA1-C1

$2,446,041
Louis Miller · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogens

$2,445,841
Christopher Parks · International Aids Vaccine Initiative · P01 · FY2017 · AI

PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM

$2,444,833
Fred Hutchinson Cancer Research Center · P50 · FY2001 · CA

ENHANCEMENT OF THE CPRC-SPF RHESUS MONKEY PROGRAM

$2,443,822
Carlos A Sariol · University Of Puerto Rico Med Sciences · U24 · FY2015 · OD

CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS

$2,443,352
Richard Rothman · Johns Hopkins University · N01 · FY2019 · AI

Applying Bioinformatics to Research in Immune, Muscle, and Bone Diseases

$2,442,797
Hong-Wei Sun · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2024 · AR

Johns Hopkins University Baltimore India Clinical Trail Unit (JHUBI CTU)

$2,442,720
Amita Gupta · Johns Hopkins University · UM1 · FY2025 · AI

PATIENT SAFETY MONITORING IN INTERNATIONAL LABORATORIES (SMILE)

$2,442,692
Robert Miller · Johns Hopkins University · N01 · FY2017 · AI

A Gene therapeutic approach to stable suppression of HIV-1 replication

$2,442,349
Michael R. Farzan · Scripps Florida · P01 · FY2014 · AI

ADVANCED PRECLINICAL DEVELOPMENT AND PRODUCTION OF MASTER SEE VIRUS OF GEO-LM01, A NOVEL MVA-VLP VACCINE AGAINST LASSA FEVER

$2,442,307
Geovax, Inc. · · FY2018 · Defense Health Agency

Advancing Transplantation Outcomes in Children

$2,441,871
David Michael Briscoe · Boston Children'S Hospital · U01 · FY2022 · AI

Targeting mTOR and CD40 Pathways for Adjuvanting HIV Vaccines

$2,440,751
Rama Rao Amara · Emory University · P01 · FY2010 · AI

Maternal and infant immunization to eliminate breast milk transmission of HIV-1

$2,440,281
Sallie R. Permar · Duke University · P01 · FY2015 · AI

Center for the Analysis & Management of the Multicenter AIDS Cohort Study

$2,439,320
Lisa P Jacobson · Johns Hopkins University · U01 · FY2011 · AI

Center/Coordination, Analysis and Management/MACS

$2,439,320
Lisa P Jacobson · Johns Hopkins University · U01 · FY2011 · AI